Showing results (1431-1440 of 1,594) with videos related to
Sort By:
Pageof 160
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 29, 2020
Identifying rare, medically relevant variation via population-based genomic screening in Alabama: opportunities and pitfallsKevin M Bowling, Michelle L Thompson, David E Gray, et al.Critical Care Medicine|November 3, 2015
Ventilator-Associated Events in Neonates and Children--A New ParadigmNoelle M Cocoros, Ken Kleinman, Gregory P Priebe, et al.Journal of Virology|December 26, 2014
A multivalent clade C HIV-1 Env trimer cocktail elicits a higher magnitude of neutralizing antibodies than any individual componentChristine A Bricault, James M Kovacs, Joseph P Nkolola, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 17, 2018
Prediction of chemotherapy-induced nausea and vomiting from patient-reported and genetic risk factorsSonam Puri, Kelly A Hyland, Kristine Crowe Weiss, et al.British Journal of Cancer|October 8, 2014
A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumoursI Brana, R Berger, T Golan, et al.Conservation Biology : the Journal of the Society for Conservation Biology|October 13, 2018
Circuit-theory applications to connectivity science and conservationBrett G Dickson, Christine M Albano, Ranjan Anantharaman, et al.The Journal of Allergy and Clinical Immunology. in Practice|April 28, 2023
Retail Food Equivalents for Post-Oral Immunotherapy Dosing in the Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen Oral Immunotherapy in Food-Allergic Children and Adults (OUtMATCH) Clinical TrialMarion Groetch, Kim Mudd, Margaret Woch, et al.Viruses|September 28, 2024
Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune ResponsesYing Huang, Shomoita Alam, Erica Andersen-Nissen, et al.Proceedings of the National Academy of Sciences of the United States of America|June 25, 2024
A metabolic inhibitor blocks cellular fucosylation and enables production of afucosylated antibodiesPierre-André Gilormini, V Narasimharao Thota, Anthony Fers-Lidou, et al.Oncotarget|October 21, 2016
Early2 factor (E2F) deregulation is a prognostic and predictive biomarker in lung adenocarcinomaLu Chen, Courtney A Kurtyka, Eric A Welsh, et al.Pageof 160